2017 Q4 Form 10-K Financial Statement

#000143774918005539 Filed on March 27, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $130.0K $500.0K $130.0K
YoY Change 0.0% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.600M $5.890M $1.640M
YoY Change -2.44% -9.8% 19.71%
% of Gross Profit
Research & Development $3.210M $13.08M $3.620M
YoY Change -11.33% -10.56% -2.16%
% of Gross Profit
Depreciation & Amortization $40.00K $553.0K $660.0K
YoY Change -93.94% -45.93% 560.0%
% of Gross Profit
Operating Expenses $4.810M $18.97M $5.260M
YoY Change -8.56% -10.31% 3.75%
Operating Profit -$18.47M
YoY Change -10.56%
Interest Expense $20.00K -$70.00K -$110.0K
YoY Change -118.18% -89.86% -57.69%
% of Operating Profit
Other Income/Expense, Net -$20.00K -$1.934M $1.290M
YoY Change -101.55% 37.74% -516.13%
Pretax Income -$4.680M -$20.40M -$5.400M
YoY Change -13.33% -7.48% -2.0%
Income Tax
% Of Pretax Income
Net Earnings -$4.680M -$20.40M -$5.400M
YoY Change -13.33% -7.49% -2.0%
Net Earnings / Revenue -3600.0% -4080.44% -4153.85%
Basic Earnings Per Share
Diluted Earnings Per Share -$312.2K -$2.674M -$2.660M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $24.17M $24.17M $4.300M
YoY Change 462.05% 462.09% -78.57%
Cash & Equivalents $11.44M $11.44M $2.624M
Short-Term Investments $12.72M $12.72M $1.680M
Other Short-Term Assets $90.00K $115.2K
YoY Change -57.14% -39.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $24.31M $24.31M $4.513M
YoY Change 438.75% 439.02% -77.75%
LONG-TERM ASSETS
Property, Plant & Equipment $175.8K $180.0K $462.8K
YoY Change -62.02% -60.87% -45.86%
Goodwill $1.976M $1.976M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.761K $10.00K $8.761K
YoY Change 0.0% -90.91% -92.04%
Total Long-Term Assets $23.03M $23.20M $25.87M
YoY Change -11.0% -11.92% -7.23%
TOTAL ASSETS
Total Short-Term Assets $24.31M $24.31M $4.513M
Total Long-Term Assets $23.03M $23.20M $25.87M
Total Assets $47.51M $47.51M $30.85M
YoY Change 54.02% 54.0% -37.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.417M $3.420M $2.879M
YoY Change 18.68% 18.75% 1.72%
Accrued Expenses $2.283M $2.280M $2.484M
YoY Change -8.09% -8.06% 29.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.560M
YoY Change -37.1%
Total Short-Term Liabilities $6.200M $6.200M $8.423M
YoY Change -26.4% -26.37% -9.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $71.71K $14.61M $12.35K
YoY Change 480.55% -6.94% -74.05%
Total Long-Term Liabilities $71.71K $14.61M $12.35K
YoY Change 480.55% -6.94% -74.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.200M $6.200M $8.423M
Total Long-Term Liabilities $71.71K $14.61M $12.35K
Total Liabilities $20.81M $20.81M $24.12M
YoY Change -13.74% -13.72% -15.78%
SHAREHOLDERS EQUITY
Retained Earnings -$261.8M -$241.4M
YoY Change 8.45% 10.66%
Common Stock $288.6M $248.2M
YoY Change 16.27% 3.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $85.19K $85.19K
YoY Change 0.0% -93.84%
Treasury Stock Shares $334.00 $334.00
Shareholders Equity $26.70M $26.70M $6.726M
YoY Change
Total Liabilities & Shareholders Equity $47.51M $47.51M $30.85M
YoY Change 54.02% 54.0% -37.08%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$4.680M -$20.40M -$5.400M
YoY Change -13.33% -7.49% -2.0%
Depreciation, Depletion And Amortization $40.00K $553.0K $660.0K
YoY Change -93.94% -45.93% 560.0%
Cash From Operating Activities -$4.210M -$16.64M -$4.660M
YoY Change -9.66% -9.45% 19.49%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $38.63K -$10.00K
YoY Change 100.0% -38.2%
Acquisitions
YoY Change
Other Investing Activities -$12.73M -$10.95M $2.840M
YoY Change -548.24% -220.07% -52.43%
Cash From Investing Activities -$12.75M -$10.99M $2.820M
YoY Change -552.13% -221.32% -52.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.71M 36.45M 280.0K
YoY Change 9082.14% 1261.44% -173.68%
NET CHANGE
Cash From Operating Activities -4.210M -16.64M -4.660M
Cash From Investing Activities -12.75M -10.99M 2.820M
Cash From Financing Activities 25.71M 36.45M 280.0K
Net Change In Cash 8.750M 8.820M -1.560M
YoY Change -660.9% -232.81% -192.31%
FREE CASH FLOW
Cash From Operating Activities -$4.210M -$16.64M -$4.660M
Capital Expenditures -$20.00K $38.63K -$10.00K
Free Cash Flow -$4.190M -$16.68M -$4.650M
YoY Change -9.89% -9.55% 19.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
135.95
CY2017Q4 clsn Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
CY2016Q4 clsn Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
22241
CY2016Q2 clsn Aggregate Of Common And Preferred Stock Shares Authorized
AggregateOfCommonAndPreferredStockSharesAuthorized
112600000
CY2017 clsn Aggregate Offering Price Additions
AggregateOfferingPriceAdditions
13500000
CY2017 clsn Amount Of Time After Effective Date Of License Agreement For Registration Rights To Take Place
AmountOfTimeAfterEffectiveDateOfLicenseAgreementForRegistrationRightsToTakePlace
P1Y
CY2017Q4 clsn Class Of Warrant Or Right Aggregate Intrinsic Value Of Outstanding Warrants
ClassOfWarrantOrRightAggregateIntrinsicValueOfOutstandingWarrants
37143
CY2016 clsn Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.14
CY2017 clsn Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
2.89
CY2016 clsn Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
62795
CY2017 clsn Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
44037
CY2016 clsn Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
209.23
CY2017 clsn Class Of Warrant Or Right Expired During Period Exercise Price
ClassOfWarrantOrRightExpiredDuringPeriodExercisePrice
174.58
CY2016 clsn Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
1147595
CY2017 clsn Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
9231628
CY2016 clsn Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
2.03
CY2017 clsn Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
3.46
CY2017 clsn Class Of Warrant Or Right Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms
P3Y182D
CY2016 clsn Class Of Warrants Or Right Exercised During Period
ClassOfWarrantsOrRightExercisedDuringPeriod
17857
CY2017 clsn Class Of Warrants Or Right Exercised During Period
ClassOfWarrantsOrRightExercisedDuringPeriod
7617147
CY2017 clsn Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
345685
CY2016 clsn Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
CY2017 clsn Deferred Finance Charges
DeferredFinanceCharges
35370
CY2016 clsn Deferred Finance Charges
DeferredFinanceCharges
236666
CY2013Q1 clsn Deferred Revenue Amortization Period
DeferredRevenueAmortizationPeriod
P10Y
CY2017 clsn Defined Contribution Plan Employer Discretionary Contribution Percent
DefinedContributionPlanEmployerDiscretionaryContributionPercent
0.06
CY2015Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
13921412
CY2016Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
13188226
CY2017Q4 clsn Earnout Milestone Liability
EarnoutMilestoneLiability
12538525
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1500000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1600000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
300000
CY2016 clsn Number Of Warrants Issued
NumberOfWarrantsIssued
1147595
CY2011Q3 clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
4200000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
1400000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
300000
clsn Operating Loss Carry Forwards Limitation On Use
OperatingLossCarryForwardsLimitationOnUse
800000
CY2017Q3 clsn Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
1200000
CY2016 clsn Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
733186
CY2017 clsn Gain Loss From Change In Fair Value Of Earn Out Milestone Liability
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
649701
CY2017 clsn Gain Loss From Valuation Of Earnout Milestone Liability
GainLossFromValuationOfEarnoutMilestoneLiability
649701
CY2016 clsn Gain Loss From Valuation Of Earnout Milestone Liability
GainLossFromValuationOfEarnoutMilestoneLiability
733186
CY2017Q4 clsn Minimum Age For Employee Benefit Plan
MinimumAgeForEmployeeBenefitPlan
21
CY2017 clsn Number Of Days Before Issuance Factoring Into Average Closing Price
NumberOfDaysBeforeIssuanceFactoringIntoAverageClosingPrice
P20D
CY2017 clsn Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
3761844
CY2016 clsn Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards
NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards
1702272
CY2017Q4 clsn Number Of Trademark Protection Application Pending For Thermo Dox
NumberOfTrademarkProtectionApplicationPendingForThermoDox
14
CY2017 clsn Number Of Warrants Issued
NumberOfWarrantsIssued
9231628
CY2017 clsn Refund Of Deposit For Letter Of Credit
RefundOfDepositForLetterOfCredit
100000
CY2016 clsn Refund Of Deposit For Letter Of Credit
RefundOfDepositForLetterOfCredit
CY2015Q3 clsn Shelf Registration Statement Amount
ShelfRegistrationStatementAmount
75000000
CY2017 clsn Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
CY2017 clsn Treasury Stock Contributed To401 K Plan
TreasuryStockContributedTo401KPlan
CY2016 clsn Treasury Stock Contributed To401 K Plan
TreasuryStockContributedTo401KPlan
101491
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
264668
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
259550
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3416863
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2878978
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-3808
CY2017Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
54440
CY2016Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
4008
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2282827
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2483756
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2838716
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2513022
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10164
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
288408976
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
248168421
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1332838
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1105245
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
345685
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5625
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1570300
CY2017Q4 us-gaap Assets
Assets
47514433
CY2016Q4 us-gaap Assets
Assets
30849691
CY2017Q4 us-gaap Assets Current
AssetsCurrent
24311701
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4512578
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
23026961
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
25874277
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12734184
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1680000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12724020
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
10164
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12724020
CY2016Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1680000
CY2017 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
CY2016 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-532
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
12538525
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13188226
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2624162
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9265144
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11444055
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8819893
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6640982
CY2017Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
24200000
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.70
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.65
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5888
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
9.39
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.29
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
790410
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
506627
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33500000
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2400000
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
421015
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1487958
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3058402
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
112500000
CY2003Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
253691
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17277299
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2230452
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56982418
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4070172
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17276965
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2230118
CY2003Q1 us-gaap Common Stock Value
CommonStockValue
2200000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
172772
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
22305
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20412340
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22049868
CY2017Q4 us-gaap Contractual Obligation
ContractualObligation
665373
CY2016Q4 us-gaap Contractual Obligation
ContractualObligation
1115193
CY2013Q1 us-gaap Deferred Revenue
DeferredRevenue
5000000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
500000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
500000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2000000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2500000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
64631000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
84049000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
62216000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
81335000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
225422000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
2415000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
2714000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
64631000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84049000
CY2017 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
77352
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
82391
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
172497
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03
CY2017 us-gaap Depreciation
Depreciation
326000
CY2016 us-gaap Depreciation
Depreciation
455000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
553010
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1022829
CY2017 us-gaap Dividends
Dividends
345685
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.72
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-11.89
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.406
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.395
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.066
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.055
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1258265
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1066751
CY2017 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7500
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7500
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
795608
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1022924
CY2016Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
75000
CY2017 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
CY2016 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
-532
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5889722
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6526752
CY2017Q4 us-gaap Goodwill
Goodwill
1976101
CY2016Q4 us-gaap Goodwill
Goodwill
1976101
CY2017Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
89186
CY2016Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
89186
CY2017 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2520000
CY2016 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
1444023
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47514433
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30849691
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
537885
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
48751
CY2017 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
50432
CY2016 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-22721
CY2017 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
59358
CY2016 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-35245
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-500000
CY2017 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-200929
CY2016 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
563987
CY2017 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-115222
CY2016 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14855
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
649701
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
733186
CY2017Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
20246491
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22766491
CY2017 us-gaap Interest And Debt Expense
InterestAndDebtExpense
91756
CY2016 us-gaap Interest And Debt Expense
InterestAndDebtExpense
722993
CY2017 us-gaap Interest Paid Net
InterestPaidNet
56386
CY2016 us-gaap Interest Paid Net
InterestPaidNet
486327
CY2017 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
26041
CY2016 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
31262
CY2017 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26041
CY2016 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26922
CY2017 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
235072
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2017Q4 us-gaap Liabilities
Liabilities
20809925
CY2016Q4 us-gaap Liabilities
Liabilities
24123865
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-20402176
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-22053726
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20747861
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22053726
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1933744
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1403906
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2016Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2560553
CY2017 us-gaap Operating Expenses
OperatingExpenses
18968432
CY2016 us-gaap Operating Expenses
OperatingExpenses
21149820
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-18468432
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6199690
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8423287
CY2017 us-gaap Licenses Revenue
LicensesRevenue
500000
CY2016 us-gaap Licenses Revenue
LicensesRevenue
500000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36454782
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2677669
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10992813
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9060713
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16642076
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18379364
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-20649820
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2212652000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
452093000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
379823000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
457995000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
454213000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
450430000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
18098000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
89000000
CY2011Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
90000000
CY2013Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
34000000
CY2013Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4000000
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
40000000
CY2017Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
35000000
CY2017Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7000000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5000000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
94521
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20021
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
115222
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8761
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8761
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10164
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3858
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-532
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10164
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3326
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71710
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12352
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2270
CY2016 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
6775016
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1680000
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
13635000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2100000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
800000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21140304
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3002
CY2017 us-gaap Payments For Rent
PaymentsForRent
502716
CY2016 us-gaap Payments For Rent
PaymentsForRent
575516
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
12734184
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4511784
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38629
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
62503
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:7.7pt;margin-top:0pt;text-align:justify;">Certain reclassifications have been made to prior year financial statements to conform to classifications used in the current year. These classifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on net loss, stockholders<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">&#x2019; equity or cash flows as previously reported.&nbsp; See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> regarding the reverse stock split which occurred on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 26, 2017. </div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
17910401
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2500
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3014487
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2975858
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175771
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462836
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
164.12
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
60449
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
535964
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2400000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
200000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2595923
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4099847
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13078710
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14623068
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-261781888
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-241379712
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
154581
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
211213
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
703442
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
1680000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2500
CY2017Q4 us-gaap Security Deposit
SecurityDeposit
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
100000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1105245
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1511023
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P8Y328D
CY2006Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
21164
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
405075
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.97
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3817
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
43735
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
80.44
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.59
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.34
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
18.08
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.69
CY2017Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
405075
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y219D
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
12724020
CY2017 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21140304
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
235072
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6775016
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17910401
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
178185
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
CY2016 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
101491
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
26704508
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
6725826
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
20385664
CY2017Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
26789696
CY2016Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
6811014
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
334
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
334
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
85188
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
85188
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7627210
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1854054
CY2016 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
132142

Files In Submission

Name View Source Status
0001437749-18-005539-index-headers.html Edgar Link pending
0001437749-18-005539-index.html Edgar Link pending
0001437749-18-005539.txt Edgar Link pending
R42.htm Edgar Link pending
0001437749-18-005539-xbrl.zip Edgar Link pending
clsn-20171231.xml Edgar Link completed
clsn-20171231.xsd Edgar Link pending
clsn-20171231_cal.xml Edgar Link unprocessable
clsn-20171231_def.xml Edgar Link unprocessable
clsn-20171231_lab.xml Edgar Link unprocessable
clsn-20171231_pre.xml Edgar Link unprocessable
clsn20171231_10k.htm Edgar Link pending
ex_108292.htm Edgar Link pending
ex_108293.htm Edgar Link pending
ex_108294.htm Edgar Link pending
ex_108295.htm Edgar Link pending
ex_108296.htm Edgar Link pending
ex_108297.htm Edgar Link pending
ex_108298.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending